Leukemia and Lymphoma Society grant program

Dear Dr. Theodorescu and colleagues,

We are pleased to announce the opening of our Career Development Program for fellows and independent investigators who are performing blood cancer research.  We encourage applicants who are doing either basic, translational/preclinical, or clinical research to apply.

We ask that you provide this information to potential applicants at your institution.

Our Award categories are:

Scholar in Clinical Research:  Early/mid career independent investigators (assistant professor/associate professor) performing clinical research.

*New in 2015:  For eligibility, time since independent appointment has been increased from 8 years to 10 years.

Scholar:  Early/mid career independent investigators (assistant professor/associate professor) performing basic or translational/preclinical research.  In some cases, clinically-related research that is wet lab-based is acceptable.

Special Fellow:  Later stage postdoctoral fellows performing basic or translational/preclinical research.  In some cases, clinically-related research that is wet lab-based is acceptable.

Fellow:  Early stage postdoctoral fellows performing basic or translational/preclinical research.  In some cases, clinically-related research that is wet lab-based is acceptable.

We have changed the application process to include an initial eligibility phase, which is used to determine eligibility based on programmatic criteria, without scientific consideration.  Key dates are as follows:

 

Eligibility Phase:  Open now

Eligibility Phase:  Closes September 1, 3:00 pm ET

Abstract Phase:  Opens upon eligibility approval (generally within a few days of eligibility submission)

Abstract Phase:  Closes September 15, 3:00 pm ET

Reference letters:  Due September 25, 2015

Full Application Phase:  Opens after Abstracts are submitted

Full Application Phase:  Closes October 1, 3:00 PM ET

 

More information regarding this program can be found on our website, or by emailing me directly.

 

Best regards,
Erik

 

:: Erik Nelson, Ph.D. | Director, Research Programs

:: The Leukemia & Lymphoma Society | 1311 Mamaroneck Avenue, Suite 310; White Plains, NY 10605

::   www.lls.org | Erik.Nelson@lls.org

 

 

About the author: Erika Matich

Erika Matich is the communications manager for the University of Colorado Cancer Center. Contact her at Erika.Matich [at] ucdenver.edu.

Comments are closed.